HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beibei Guo Selected Research

Radiotherapy

1/2024Dynamic role of CUL4B in radiation-induced intestinal injury-regeneration.
1/2023Challenges in the combination of radiotherapy and immunotherapy for breast cancer.
1/2023A Bayesian phase I/II design to determine subgroup-specific optimal dose for immunotherapy sequentially combined with radiotherapy.
4/2022Flattening Filter-Free Volumetric-Modulated Arc Radiotherapy for Left-Sided Whole-Breast, Partial-Breast, and Postmastectomy Irradiations.
12/2020Comparison of conventional and advanced radiotherapy techniques for left-sided breast cancer after breast conserving surgery.
4/2020Postmastectomy radiotherapy for left-sided breast cancer patients: Comparison of advanced techniques.
1/2020Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients.
7/2018Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: Bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beibei Guo Research Topics

Disease

28Neoplasms (Cancer)
01/2024 - 01/2016
7Breast Neoplasms (Breast Cancer)
01/2023 - 07/2018
6AIDS-Related Complex (ARC)
04/2022 - 07/2018
5Neoplasm Metastasis (Metastasis)
01/2023 - 02/2020
4Acute-On-Chronic Liver Failure
03/2024 - 06/2020
3Inflammation (Inflammations)
03/2024 - 01/2022
3Lung Neoplasms (Lung Cancer)
01/2022 - 04/2020
2Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 01/2022
2Triple Negative Breast Neoplasms
07/2023 - 01/2022
2Asthma (Bronchial Asthma)
01/2023 - 01/2022
2Melanoma (Melanoma, Malignant)
10/2022 - 10/2021
2Bites and Stings (Sting)
10/2022 - 01/2022
2Wounds and Injuries (Trauma)
08/2022 - 01/2021
2Acute Liver Failure (Fulminant Hepatic Failure)
01/2022 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2020
2Unilateral Breast Neoplasms
12/2020 - 04/2020
2Hepatocellular Carcinoma (Hepatoma)
10/2020 - 01/2020
1Constipation
03/2024
1Fatigue
03/2024
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
03/2024
1Weight Gain
03/2024
1Pathologic Processes
01/2024
1Prostatic Neoplasms (Prostate Cancer)
10/2023
1Fibrosis (Cirrhosis)
10/2023
1Hepatitis B
01/2023
1Allergic Rhinitis
01/2023
1Hypersensitivity (Allergy)
01/2023
1Liver Failure
01/2023
1End Stage Liver Disease
01/2023
1Ovarian Epithelial Carcinoma
09/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2022
1Hypoxia (Hypoxemia)
08/2022
1Infarction (Infarctions)
08/2022
1Disease Progression
01/2022
1Chronic Hepatitis B
01/2022
1Glioma (Gliomas)
01/2022
1Brain Diseases (Brain Disorder)
11/2021
1Burns
01/2021

Drug/Important Bio-Agent (IBA)

4DisulfidesIBA
10/2023 - 10/2020
3Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2020
3Docetaxel (Taxotere)FDA Link
10/2023 - 04/2020
3CytokinesIBA
01/2023 - 01/2022
3Peptides (Polypeptides)IBA
01/2022 - 10/2020
2IntegrinsIBA
10/2023 - 04/2020
2Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2023
2Paclitaxel (Taxol)FDA LinkGeneric
07/2023 - 01/2022
2GemcitabineFDA Link
07/2023 - 01/2022
2Apolipoproteins E (ApoE)IBA
01/2022 - 10/2020
2MicroRNAs (MicroRNA)IBA
01/2022 - 01/2022
2MicellesIBA
01/2022 - 10/2020
1Inosine Monophosphate (IMP)IBA
03/2024
1Thrombospondin 1IBA
03/2024
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2024
1Arginine Vasopressin (Argipressin)IBA
10/2023
1A-factor (Streptomyces)IBA
10/2023
1AllergensIBA
01/2023
1Therapeutic UsesIBA
01/2023
1LipopolysaccharidesIBA
01/2023
1HMGB1 Protein (HMG1)IBA
01/2023
1SodiumIBA
01/2023
1ADU-S100IBA
10/2022
1InterferonsIBA
10/2022
1BI 6727IBA
09/2022
1lupaneIBA
08/2022
1Creatine Kinase (Creatine Phosphokinase)IBA
08/2022
1EnzymesIBA
08/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2022
1Phosphotransferases (Kinase)IBA
08/2022
1TriterpenesIBA
08/2022
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
08/2022
1Caspase 3 (Caspase-3)IBA
08/2022
1acetyl- lysyl- prolyl- seryl- seryl- prolyl- prolyl- glutamyl- glutamic acid amideIBA
01/2022
1ProdrugsIBA
01/2022
1CPG-oligonucleotideIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Granzymes (Granzyme)IBA
01/2022
1MethoxyhydroxyphenylglycolIBA
01/2022
1Urea (Carbamide)FDA LinkGeneric
11/2021
1BilirubinIBA
11/2021
1LTX-315IBA
10/2021
1Interleukin-6 (Interleukin 6)IBA
10/2021
1Leucine (L-Leucine)FDA Link
01/2021
1UCON 50-HB-5100 (F127)IBA
01/2021
1Polyvinyl AlcoholIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1Bromelains (Bromelain)IBA
01/2021
1Photosensitizing Agents (Photosensitizers)IBA
01/2021
1HydrogelsIBA
01/2021

Therapy/Procedure

16Therapeutics
10/2023 - 01/2016
15Immunotherapy
01/2024 - 01/2016
8Radiotherapy
01/2024 - 07/2018
5Drug Therapy (Chemotherapy)
12/2022 - 01/2018
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2021 - 01/2020
3Transplantation
01/2023 - 01/2020
2Liver Transplantation
03/2023 - 06/2020
2Mastectomy (Mammectomy)
04/2020 - 01/2020
1Conservative Treatment
03/2024
1Radioimmunotherapy
01/2023
1Adjuvant Chemotherapy
09/2022
1Intravenous Administration
09/2022